DCGI gives approval for Itolizumab, for Covid treatment


Deprecated: strlen(): Passing null to parameter #1 ($string) of type string is deprecated in /home/medicircle/public_html/script_newsdetails.php on line 75
▴ dcgi-okays-psoriasis-injection-treating-covid-patients
Psoriasis injection okayed for limited use to treat Coronavirus patients by drug controller

Psoriasis injection Itolizumab, which is used to cure skin ailment, has been approved for limited use in treating coronavirus, Drug Controller General of India (DCGI) has said. India's drug controller has okayed emergency use of Psoriasis injection for treating COVID-19 patients with moderate to severe acute respiratory distress.

Considering the unmet medical needs to treat COVID-19, Drugs Controller General of India Dr. VG Somani approved monoclonal antibody injection Itolizumab for restricted emergency use for the treatment of 'cytokine' release syndrome in moderate to severe acute respiratory distress syndrome patients due to COVID-19.

"The approval was given after its clinical trials on COVID-19 patients in India was found satisfactory by the expert committee comprising pulmonologists, pharmacologists and medicine experts from AIIMS, among others, for treatment of cytokine release syndrome," an official told PTI.

"It is already an approved drug of Biocon for treating psoriasis for the last many years," the official said.

Written informed consent of each patient is required before the use of this drug, he said.

With a record single-day increase of 27,114 cases, India's COVID-19 tally zoomed past the eight-lakh mark on Saturday, just four days after crossing the seven-lakh post, according to health ministry data. This was the eighth consecutive day that COVID-19 cases in the country increased by more than 22,000. According to data updated at 8 am, the death toll climbed to 22,123 with 519 people succumbing to the disease in 24 hours.

While the total coronavirus caseload surged to 8,20,916 on Saturday, there were 2,83,407 active cases and 5,15,385 recoveries. The total number of confirmed cases include foreigners. Thus, around 62.78 percent of patients have recovered so far," an official said. Of the 519 new deaths reported, 226 are from Maharashtra, 64 from Tamil Nadu, 57 from Karnataka, 42 from Delhi, 27 from Uttar Pradesh and 26 from West Bengal. Andhra Pradesh reported 15 fatalities, Gujarat 14, Telangana eight and Rajasthan six.

Assam, and Jammu and Kashmir reported five deaths, followed by Bihar, Madhya Pradesh, Odisha and Punjab with four deaths each from, Haryana and Puducherry three fatalities each while two persons have succumbed to the viral infection in Chhattisgarh.

PTI

Tags : #DCGI #Psoriasis #Itoluzimab #CovidTreatment #Biocon #IndiaCovidNews #PharmaNews

About the Author


Team Medicircle

Related Stories

Loading Please wait...

-Advertisements-




Trending Now

Digital Identity Fraud in Healthcare: What India Must KnowNovember 18, 2026
Wearables in Clinical Care: When Should Doctors Trust the Data?November 18, 2026
Cybersecurity for Medical Startups: What Founders MissNovember 18, 2026
Remote Patient Monitoring: The Next Phase of Virtual CareNovember 18, 2026
Digital Health Wallets: Future of Medical Records in IndiaNovember 17, 2026
How Hospitals Can Prepare for a Transparent Healthcare MarketNovember 17, 2026
Childhood Nutrition: Understanding Micronutrient Gaps Beyond CaloriesNovember 16, 2026
Anaemia in Adolescent Girls: Connecting Prevention, Testing and Nutrition SupportNovember 16, 2026
Health Information Exchanges in India: Are Medical Records Finally Going Portable?November 16, 2026
Hospital Accreditation in 2026: What Is Changing Beyond the Checklist?November 16, 2026
Digital Insurance Platforms and India's Health Coverage FutureNovember 14, 2026
ABDM 2.0: India's Digital Health Ecosystem FutureNovember 14, 2026
Vaccine Cold-Chain Management: Protecting Immunisation Quality From Storage to DeliveryNovember 14, 2026
Foodborne Illness Surveillance: How Public Health Systems Track RisksNovember 14, 2026
Interoperability in Indian Healthcare: Why Patient Data Still StrugglesNovember 13, 2026
Tuberculosis Contact Screening: How Preventive Care Works Around ExposureNovember 13, 2026
COPD Care in India: Linking Diagnosis, Inhaler Education and Follow-UpNovember 13, 2026
Management of ANCA Glomerulonephritis: Induction & Maintenance ProtocolsNovember 12, 2026
Smart Hospital Command Centres Transforming IndiaNovember 12, 2026
Gamma Knife Surgery in India: What You Need to KnowNovember 12, 2026